Journal List > Clin Nutr Res > v.3(1) > 1059768

Clin Nutr Res. 2014 Jan;3(1):1-8. English.
Published online Jan 27, 2014.  https://doi.org/10.7762/cnr.2014.3.1.1
© 2014 The Korean Society of Clinical Nutrition
Nutrition, Epigenetics, and Diseases
Hyeran Jang,1,2 and Carlo Serra1,2
1Division of Endocrinology, Diabetes and Hypertension, Brigham and Women's Hospital, Boston, MA 02115, USA.
2Harvard Medical School, Boston, MA 02115, USA.

Corresponding author: Hyeran Jang. Address: Division of Endocrinology, Diabetes and Hypertension Brigham and Women's Hospital/HMS 221 Longwood ave. EBRC-212 Boston, MA 02115, USA. Tel +1-617-525-9054, Fax +1-617-582-6193, Email: hjang1@partners.org
Received November 28, 2013; Revised December 21, 2013; Accepted December 21, 2013.

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.


Abstract

Increasing epidemiological evidence suggests that maternal nutrition and environmental exposure early in development play an important role in susceptibility to disease in later life. In addition, these disease outcomes seem to pass through subsequent generations. Epigenetic modifications provide a potential link between the nutrition status during critical periods in development and changes in gene expression that may lead to disease phenotypes. An increasing body of evidence from experimental animal studies supports the role of epigenetics in disease susceptibility during critical developmental periods, including periconceptional period, gestation, and early postnatal period. The rapid improvements in genetic and epigenetic technologies will allow comprehensive investigations of the relevance of these epigenetic phenomena in human diseases.

Keywords: Nutrition; Reprogramming; Development; Epigenetic; Disease

Introduction

Many human diseases that appear in adulthood are related to growth patterns during early life. It is now recognized that early-life nutrition and other environmental factors play key roles in the pathogenesis and in the predisposition of specific human diseases. In this regard, in 1995 Dr. Barker wrote: "The fetal origins hypothesis states that fetal undernutrition in middle to late gestation, which leads to disproportionate fetal growth, programs later coronary heart disease."[1]. The word "program" illustrates the idea that the environmental stimuli received during critical periods of early fetal development can generate permanent changes in body structure and function that affect the homeostasis of specific organs in the adult life [2]. The responsiveness of a growing body to external cues is defined as developmental plasticity. Developmental plasticity derives from the ability of our genes to organize different ranges of physiological or morphological states in response to environmental conditions during fetal development. In this review we focus on particular situations in human and experimental animal models to underline the link between nutritional and environmental stimuli during critical periods of the early development and the susceptibility to disease development in the adult life.

Dutch Famine Birth Cohort

Insights in the importance of nutritional supply during a critical period on long-term disease outcome were gained from the Dutch Famine cohort. The Dutch Famine cohort is one of the most well-known cohorts that have been used to investigate the effects of prenatal undernutrition in humans. During the Nazi occupation from November 1944 to May 1945, food supply was extremely limited in some parts of the Netherlands. Daily rations during this famine period started at less than 1,000 kcal in November 1944, and decreased to about 500 kcal by April 1945. This six month food shortage had a major impact on particular situations, such as ongoing pregnancies. From 1998, the Dutch Famine Birth Cohort Study began reporting the outcome of pregnancies that occurred during this famine period and the consequences of massive maternal undernutrition on the offspring on a long-term scale [3-5]. Results showed an increased risk of cardiovascular diseases 40-50 years later in those children born to mothers who experienced extremely severe undernutrition during the first trimester of pregnancy [6]. The incidence of cardiovascular diseases was 2 times higher in this group compared to the control cohort [6]. Also, the serious nutritional deprivation increased the risk of metabolic disorders and breast cancer decades later in this cohort [7-9]. Notably, depending on the period of starvation (early versus late pregnancy, and preconceptional versus postnatal undernutrition) marked differences in disease outcomes were observed, indicating that the first trimester of pregnancy is particularly vulnerable to disease outcome in adulthood.

Why Your DNA Isn't Your Destiny

Another interesting epidemiological study pointed out the importance of nutritional status during puberty and its impact on the offspring's health, by investigating if the availability of food to one generation affected longevity and health of the descendants. This study conducted by Dr. Bygren, investigated the long-term effects of feast and famine on children growing up in the isolated Swedish county of Norrbotten, with the goal to unravel whether "Parents' experiences early in their lives change the traits they passed to their offspring" [10]. In the 19th century, Norrbotten was so isolated that if the harvest failed, people starved. Harvest failures occurred erratically, causing famines in 1800, 1812, 1821, 1836 and 1856. Bygren and colleagues found that if an individual went through a famine as a teenager, his or her grandchildren would have shown higher mortality risk ratio, but only if the grandchildren were the same sex as the grandparent who starved [10, 11]. Starvation of a male only changed his grandson's mortality risk and starvation of a female only changed her granddaughter's mortality risk [10, 11].

Early nutrition and onset of metabolic phenotype in adult

The three main insights of a number of studies from the Dutch and Norrbotten's cohorts are: 1) there may be critical developmental time windows where overnutrition or undernutrition may promote or impede disease development; 2) epigenetic factors can be modified by hunger exposure during these critical time windows; and 3) acquired epigenetic alterations are passed on to offspring. To better address these points, various animal models have been developed to explore whether nutritional or environmental modifications over critical developmental windows affect lifelong disease risk. It has been shown, for example, that overfeeding dams during gestation and lactation with high-caloric diet or reducing the number of pups in a litter could indirectly overnourish pups. Table 1 and Table 2 summarize some of the results observed in the offspring's phenotype induced by specific maternal dietary effects in different developmental time windows and in different experimental models. From these animal studies we can conclude that maternal overnutrition or undernutrition may act as an early mechanism of programming of the developing embryo/fetus, and may instruct a status of 'metabolic stress', restricting early embryonic cell proliferation and the generation of appropriately sized stem-cell pools. These observed phenotypic changes are dictated by the epigenetic-based molecular mechanisms that govern stability, transfer and expression of the eukaryotic genome.


Table 1
Experimental animal models with maternal dietary modifications during development or early life, and their impact on phenotype of offspring
Click for larger image


Table 2
Rodent small litter models of postnatal overnutrition, and their impact on metabolic phenotype
Click for larger image

Epigenetics

Since the Human Genome Project completed sequencing the 3 billion chemical base pairs that make up human DNA in April 2003, it became clear not only that we are able to read nature's complete genetic blueprint, but also that the information stored in the sequence of the DNA is not enough per se to completely explain human development, physiology and disease. The field dedicated to decipher the heritable features that complements the genetic information stored in the DNA sequence is termed "epigenetics". The prefix epi- is derived from the Greek preposition έπί, meaning above, on or over. Formally, epigenetics refers to the study of heritable changes in gene expression that are not caused by changes in the DNA sequence [12]. In a more practical sense, epigenetics includes the study of DNA modifications, the post-translational changes of the protein constituents of the chromatin, namely the histones, the chromatin modifications that appear to define biologic states in local regions of chromosomes, and the interaction of microRNAs with the genome [13]. Recent epigenetic studies have, for example, highlighted the mechanistic nature of the interactions between DNA and the enzymes that perform DNA replication, transcription, recombination, and repair [14].

DNA methylation

DNA methylation is a common modification in mammalian genomes and is considered a stable epigenetic mark transmitted through DNA replication and cell division [15]. Methylation is a covalent binding of a chemical methyl group to the cytosine (C) base in DNA sequence, specifically at CpG (cytosine-phosphate-guanine) dinucleotides. Methylation of C is typically associated with the 5' end of gene sequences, where CpG dinucleotides islands are particularly dense. Hypermethylation of the CpG islands is associated with transcriptional repression, while their hypomethylation is associated with the transcriptional activation of surrounding genes [16]. DNA methylation established during development and early postnatal life plays critical roles to regulate cell- and tissue-specific gene expression and genomic imprinting. Genomic imprinting is an epigenetic phenomenon in which the expression of a gene copy depends on its parent of origin [15, 17], the significance of DNA methylation in genomic imprinting was highlighted in CpG islands of imprinted genes such as IGF2 and H19 [18]. In normal cells, the paternal IGF2 and maternal H19 gene are expressed while maternal IGF2 and paternal H19 are silenced by DNA methylation [19]. De novo DNA methylation is catalyzed by the DNA methyltransferases (DNMT) 3A and 3B, whereas DNA methylation is maintained after the replication of the DNA by DNMT1, which methylates hemi-methylated DNA [17]. Once established, DNA methylation is essentially maintained throughout life; however, a gradual hypomethylation occurs during aging, and it has been linked with some types of cancer [20].

Histone modification

The DNA in the cells is packaged as chromatin. The basic unit of chromatin is a nucleosome, which comprises 147 bp of DNA wrapped around a core of 8 histone proteins (two copies of histone H2A, H2B, H3 and H4) [21]. The N-terminal tails of the histones are subject to post-translational modifications including acetylation, methylation, ubiquitination, sumoylation, and phosphorylation [22]. Histone modifications lead to structural changes of the chromatin, and to the recruitment of effector proteins, for example transcription factors, which in turn bring about specific cellular processes by modulating target gene expression. Histone acetylation is exclusively associated with active and open chromatin states, while the methylation of lysine residues in the N-terminal of histones can either be an active or repressive mark depending on the specific lysine involved [23]. Many families of histone-modifying enzymes have been identified, including histone acetyl transferases, deacetylases, methyltransferases, and demethylases [24].

Non-coding RNAs

Non-coding RNAs (ncRNAs) have been implicated in the epigenetic regulation of gene expression by gene silencing or target mRNA degradation. Recent studies have shown that human miRNAs can induce chromatin remodeling [25, 26], suggesting that DNA methylation, histone modification and miRNAs may work in concert to regulate gene expression.

Developmental plasticity

During the development of multicellular organisms, different cells and tissues acquire different programs of gene expression. It is well recognized that a series of precisely timed and regulated epigenetic changes are required to ensure the proper development of complex organisms like humans [15, 27]. At the morula stage, an early step of embryonic development, DNA demethylation occurs to erase all of the parent-of-origin methylation marks, except those of the imprinted genes. This allows for the inheritance of parental-specific monoallelic expression in somatic tissues throughout adulthood. This demethylation phase is followed by the de novo DNA methylation of the genome to establish the proper methylation patterns of the growing organism [28]. In such a way, as the embryo grows the offspring acquires their appropriate epigenetic features. In parallel to these changes occurring in somatic cells, another set of genomic reprogramming takes place in the cells of the germ line during gametogenesis [29]. In fact, during gonadal sex determination, primordial germ cells undergo genome-wide demethylation, which erases previous parental-specific methylation marks. Afterward, for example in the male germ line, paternal methylation marks occur in specific genes in the gonocytes that subsequently will develop into spermatogonia. Conversely, the female germ line establishes maternal methylation marks of imprinted genes at a later stage. In addition to DNA methylation, histone modifications are thought to play a role in the establishment of both sex-specific and non sex-specific marks because an extensive loss of histone methylation and acetylation occurs along with the loss of DNA methylation at the morula stage [30]. Epigenetic marks assure the proper expression of the imprinted genes throughout the embryonic development. For example, genomic imprinting results in the monoallelic, parent-of-origin dependent expression of genes specifically required for key developmental steps. It is predictable from this scenario that the aberrant methylation of imprinted genes, mostly loss of imprinting (LOI) in the early stages of development, can alter the expression of critical genes, and then may bring out birth defects and adulthood diseases such as cancer [31]. In this regard, given the nature of the monoallelic expression, imprinted genes are particularly susceptible to the effect of epigenetic aberrations. In addition, for the strict dependence of these early steps of development to nutritional support, inherited and acquired epigenetic marks are particularly vulnerable to the interference coming from environmental stimuli [32].

Early life nutrition and altered epigenetic regulation

Due to the dynamic changes of the epigenetic regulation in development, particularly during gametogenesis and early embryogenesis, the epigenome displays labile nature, which allows it to respond and adapt to environmental stressors, including nutritional modification. For instance, periconceptional supplementation or restriction of the maternal diet with betaine, choline, folic acid, methionine, or vitamin B-12 in experimental models have been shown to affect the establishment of DNA methylation patterns, altering the gene expression and phenotype of the offspring [33]. Three main experimental approaches are in use to better understand the underlying mechanism by which nutritional modifications affect the epigenetic profile during critical developmental windows: 1) the study of epigenetically labile study of epigenetically labile genes, such as the insulin-like growth factor 2 (IGF2) gene; 2) the use of specific, natural animal models, such as the agouti mice; and 3) the targeting of a specific organ that is central for energy metabolism using dietary modification.

Insulin-like growth factor II (IGF2)

IGF2 is a key protein in human growth and development [34]. The IGF2 gene is maternally imprinted and is one of the best-characterized epigenetically regulated loci [32]. The imprinting of this locus is maintained through the methylation of a DNA sequence named the differentially methylated region (DMR), the hypomethylation of which leads to bi-allelic expression of the IGF2 gene. As illustrated by retrospective studies from the Dutch famine cohort [35] as well as in experimental animal studies [36-38], the IGF2 gene has been shown to be characterized by a labile methylation pattern depending on the nutritional or environmental stimuli received by the growing organism during the early life. Table 3 summarizes some data that support the observed developmental plasticity of the IGF2 locus. Notably, post-weaning mice fed a methyl-deficient diet exhibit permanent LOI and dysregulated expression of the IGF2 gene [37], suggesting that both childhood and maternal diet contribute to the LOI in the IGF2 locus in humans.


Table 3
Effect of maternal dietary modifications on imprinted gene, IGF2
Click for larger image

Agouti model

The agouti mouse has been extensively used to investigate the phenotypic impact of the nutritional modification during critical developmental periods, and the environmental influence on the fetal epigenome [39]. The agouti viable yellow (Avy) locus regulates mouse coat color; more importantly, the product of the agouti gene interferes with the regulation of body weight at the level of the hypothalamus. DNA hypomethylation of the agouti gene promoter results in the accumulation of the agouti protein; as consequence, the mouse develops a yellow coat color as well as obesity. Conversely, hypermethylation of the promoter reduces the level of the agouti protein, and this, consequently, results in mice with lean phenotype and brown coat color. Interestingly, feeding agouti female pregnant mice with a diet enriched with methyl donor supplementation such as folic acid, vitamin B12, choline and betaine has been shown to modify the phenotype of their heterozygote offspring [40]. This effect was confirmed to be mediated by the hypermethylation of the Avy promoter in the offspring of supplemented dams [41]. Table 4 provides additional evidences that specific maternal dietary treatments or environmental factors affect the phenotype of the agouti offspring through epigenetic mechanism.


Table 4
Effects of maternal diet or environmental factors on yellow agouti offspring
Click for larger image

Hypothalamic DNA methylation

The central brain region integrates various peripheral signals to regulate energy balance [42]. The hypothalamus plays a key role in the regulation of food intake and energy expenditure. For these reasons, the hypothalamus is an excellent organ candidate to study the epigenetic changes that mediate the developmental reprogramming of energy metabolism. Not surprisingly, maternal overnutrition [43-46] and undernutrition [47, 48] have been shown to alter hypothalamic DNA methylation. These changes in DNA methylation have been reported to persist from early life to adulthood [43, 46], affecting the overall metabolism in the adult.

Conclusion

Developing organisms seem to have a wide range of susceptibility to epigenetic changes [49]. Appropriate dynamics in epigenetic modifications are essential for embryogenesis, early fetal development and early postnatal growth. Consequently, the inadequate establishment of epigenetic modifications during critical developmental periods due to changes in the maternal diet or other environmental factors may induce pediatric developmental diseases and even affect health in adulthood. Since much of the reprogramming that occurs during early life may go unrecognized until adulthood, a better understanding of the interplay between genetic and epigenetic interaction in critical time windows of development would improve our ability to determine individual susceptibility to a wide range of diseases.

Notes

We declare that we have no conflict of interest.

References
1. Barker DJ. Fetal origins of coronary heart disease. BMJ 1995;311:171–174.
2. Byrne CD, Phillips DI. Fetal origins of adult disease: epidemiology and mechanisms. J Clin Pathol 2000;53:822–828.
3. Roseboom TJ, Painter RC, van Abeelen AF, Veenendaal MV, de Rooij SR. Hungry in the womb: what are the consequences? Lessons from the Dutch famine. Maturitas 2011;70:141–145.
4. Painter RC, Osmond C, Gluckman P, Hanson M, Phillips DI, Roseboom TJ. Transgenerational effects of prenatal exposure to the Dutch famine on neonatal adiposity and health in later life. BJOG 2008;115:1243–1249.
5. Roseboom T, de Rooij S, Painter R. The Dutch famine and its long-term consequences for adult health. Early Hum Dev 2006;82:485–491.
6. Painter RC, de Rooij SR, Bossuyt PM, Simmers TA, Osmond C, Barker DJ, Bleker OP, Roseboom TJ. Early onset of coronary artery disease after prenatal exposure to the Dutch famine. Am J Clin Nutr 2006;84:322–327.
7. de Rooij SR, Painter RC, Roseboom TJ, Phillips DI, Osmond C, Barker DJ, Tanck MW, Michels RP, Bossuyt PM, Bleker OP. Glucose tolerance at age 58 and the decline of glucose tolerance in comparison with age 50 in people prenatally exposed to the Dutch famine. Diabetologia 2006;49:637–643.
8. Painter RC, De Rooij SR, Bossuyt PM, Osmond C, Barker DJ, Bleker OP, Roseboom TJ. A possible link between prenatal exposure to famine and breast cancer: a preliminary study. Am J Hum Biol 2006;18:853–856.
9. de Rooij SR, Painter RC, Holleman F, Bossuyt PM, Roseboom TJ. The metabolic syndrome in adults prenatally exposed to the Dutch famine. Am J Clin Nutr 2007;86:1219–1224.
10. Bygren LO, Kaati G, Edvinsson S. Longevity determined by paternal ancestors' nutrition during their slow growth period. Acta Biotheor 2001;49:53–59.
11. Pembrey ME, Bygren LO, Kaati G, Edvinsson S, Northstone K, Sjöström M, Golding J. ALSPAC Study Team. Sex-specific, male-line transgenerational responses in humans. Eur J Hum Genet 2006;14:159–166.
12. Bird A. Perceptions of epigenetics. Nature 2007;447:396–398.
13. Wade PA, Archer TK. Epigenetics: environmental instructions for the genome. Environ Health Perspect 2006;114:A140–A141.
14. Musselman CA, Lalonde ME, Côté J, Kutateladze TG. Perceiving the epigenetic landscape through histone readers. Nat Struct Mol Biol 2012;19:1218–1227.
15. Bird A. DNA methylation patterns and epigenetic memory. Genes Dev 2002;16:6–21.
16. Bird AP. CpG-rich islands and the function of DNA methylation. Nature 1986;321:209–213.
17. Reik W, Dean W, Walter J. Epigenetic reprogramming in mammalian development. Science 2001;293:1089–1093.
18. Li E, Beard C, Jaenisch R. Role for DNA methylation in genomic imprinting. Nature 1993;366:362–365.
19. Rainier S, Johnson LA, Dobry CJ, Ping AJ, Grundy PE, Feinberg AP. Relaxation of imprinted genes in human cancer. Nature 1993;362:747–749.
20. Gonzalo S, Jaco I, Fraga MF, Chen T, Li E, Esteller M, Blasco MA. DNA methyltransferases control telomere length and telomere recombination in mammalian cells. Nat Cell Biol 2006;8:416–424.
21. Luger K, Mäder AW, Richmond RK, Sargent DF, Richmond TJ. Crystal structure of the nucleosome core particle at 2.8 A resolution. Nature 1997;389:251–260.
22. Berger SL. An embarrassment of niches: the many covalent modifications of histones in transcriptional regulation. Oncogene 2001;20:3007–3013.
23. Jenuwein T, Allis CD. Translating the histone code. Science 2001;293:1074–1080.
24. Cole PA. Chemical probes for histone-modifying enzymes. Nat Chem Biol 2008;4:590–597.
25. Kim DH, Saetrom P, Snøve O Jr, Rossi JJ. MicroRNA-directed transcriptional gene silencing in mammalian cells. Proc Natl Acad Sci U S A 2008;105:16230–16235.
26. Szenthe K, Koroknai A, Banati F, Bathori Z, Lozsa R, Burgyan J, Wolf H, Salamon D, Nagy K, Niller HH, Minarovits J. The 5' regulatory sequences of active miR-146a promoters are hypomethylated and associated with euchromatic histone modification marks in B lymphoid cells. Biochem Biophys Res Commun 2013;433:489–495.
27. Li E. Chromatin modification and epigenetic reprogramming in mammalian development. Nat Rev Genet 2002;3:662–673.
28. Bernal AJ, Jirtle RL. Epigenomic disruption: the effects of early developmental exposures. Birth Defects Res A Clin Mol Teratol 2010;88:938–944.
29. Jirtle RL, Skinner MK. Environmental epigenomics and disease susceptibility. Nat Rev Genet 2007;8:253–262.
30. Weaver JR, Susiarjo M, Bartolomei MS. Imprinting and epigenetic changes in the early embryo. Mamm Genome 2009;20:532–543.
31. DeBaun MR, Niemitz EL, McNeil DE, Brandenburg SA, Lee MP, Feinberg AP. Epigenetic alterations of H19 and LIT1 distinguish patients with Beckwith-Wiedemann syndrome with cancer and birth defects. Am J Hum Genet 2002;70:604–611.
32. Murphy SK, Jirtle RL. Imprinting evolution and the price of silence. Bioessays 2003;25:577–588.
33. Sinclair KD, Allegrucci C, Singh R, Gardner DS, Sebastian S, Bispham J, Thurston A, Huntley JF, Rees WD, Maloney CA, Lea RG, Craigon J, McEvoy TG, Young LE. DNA methylation, insulin resistance, and blood pressure in offspring determined by maternal periconceptional B vitamin and methionine status. Proc Natl Acad Sci U S A 2007;104:19351–19356.
34. Reik W, Constancia M, Dean W, Davies K, Bowden L, Murrell A, Feil R, Walter J, Kelsey G. Igf2 imprinting in development and disease. Int J Dev Biol 2000;44:145–150.
35. Heijmans BT, Tobi EW, Stein AD, Putter H, Blauw GJ, Susser ES, Slagboom PE, Lumey LH. Persistent epigenetic differences associated with prenatal exposure to famine in humans. Proc Natl Acad Sci U S A 2008;105:17046–17049.
36. Kwong WY, Miller DJ, Ursell E, Wild AE, Wilkins AP, Osmond C, Anthony FW, Fleming TP. Imprinted gene expression in the rat embryo-fetal axis is altered in response to periconceptional maternal low protein diet. Reproduction 2006;132:265–277.
37. Waterland RA, Lin JR, Smith CA, Jirtle RL. Post-weaning diet affects genomic imprinting at the insulin-like growth factor 2 (Igf2) locus. Hum Mol Genet 2006;15:705–716.
38. Claycombe KJ, Uthus EO, Roemmich JN, Johnson LK, Johnson WT. Prenatal low-protein and postnatal high-fat diets induce rapid adipose tissue growth by inducing Igf2 expression in Sprague Dawley rat offspring. J Nutr 2013;143:1533–1539.
39. Dolinoy DC. The agouti mouse model: an epigenetic biosensor for nutritional and environmental alterations on the fetal epigenome. Nutr Rev 2008;66 Suppl 1:S7–S11.
40. Wolff GL, Kodell RL, Moore SR, Cooney CA. Maternal epigenetics and methyl supplements affect agouti gene expression in Avy/a mice. FASEB J 1998;12:949–957.
41. Waterland RA, Jirtle RL. Early nutrition, epigenetic changes at transposons and imprinted genes, and enhanced susceptibility to adult chronic diseases. Nutrition 2004;20:63–68.
42. Flier JS. Obesity wars: molecular progress confronts an expanding epidemic. Cell 2004;116:337–350.
43. Li G, Kohorst JJ, Zhang W, Laritsky E, Kunde-Ramamoorthy G, Baker MS, Fiorotto ML, Waterland RA. Early postnatal nutrition determines adult physical activity and energy expenditure in female mice. Diabetes 2013;62:2773–2783.
44. Plagemann A, Harder T, Brunn M, Harder A, Roepke K, Wittrock-Staar M, Ziska T, Schellong K, Rodekamp E, Melchior K, Dudenhausen JW. Hypothalamic proopiomelanocortin promoter methylation becomes altered by early overfeeding: an epigenetic model of obesity and the metabolic syndrome. J Physiol 2009;587:4963–4976.
45. Plagemann A, Roepke K, Harder T, Brunn M, Harder A, Wittrock-Staar M, Ziska T, Schellong K, Rodekamp E, Melchior K, Dudenhausen JW. Epigenetic malprogramming of the insulin receptor promoter due to developmental overfeeding. J Perinat Med 2010;38:393–400.
46. Vucetic Z, Kimmel J, Totoki K, Hollenbeck E, Reyes TM. Maternal high-fat diet alters methylation and gene expression of dopamine and opioid-related genes. Endocrinology 2010;151:4756–4764.
47. Begum G, Stevens A, Smith EB, Connor K, Challis JR, Bloomfield F, White A. Epigenetic changes in fetal hypothalamic energy regulating pathways are associated with maternal undernutrition and twinning. FASEB J 2012;26:1694–1703.
48. Coupé B, Amarger V, Grit I, Benani A, Parnet P. Nutritional programming affects hypothalamic organization and early response to leptin. Endocrinology 2010;151:702–713.
49. Gluckman PD, Hanson MA, Buklijas T, Low FM, Beedle AS. Epigenetic mechanisms that underpin metabolic and cardiovascular diseases. Nat Rev Endocrinol 2009;5:401–408.
50. Watkins AJ, Wilkins A, Cunningham C, Perry VH, Seet MJ, Osmond C, Eckert JJ, Torrens C, Cagampang FR, Cleal J, Gray WP, Hanson MA, Fleming TP. Low protein diet fed exclusively during mouse oocyte maturation leads to behavioural and cardiovascular abnormalities in offspring. J Physiol 2008;586:2231–2244.
51. Kwong WY, Wild AE, Roberts P, Willis AC, Fleming TP. Maternal undernutrition during the preimplantation period of rat development causes blastocyst abnormalities and programming of postnatal hypertension. Development 2000;127:4195–4202.
52. Oben JA, Mouralidarane A, Samuelsson AM, Matthews PJ, Morgan ML, McKee C, Soeda J, Fernandez-Twinn DS, Martin-Gronert MS, Ozanne SE, Sigala B, Novelli M, Poston L, Taylor PD. Maternal obesity during pregnancy and lactation programs the development of offspring non-alcoholic fatty liver disease in mice. J Hepatol 2010;52:913–920.
53. Oben JA, Patel T, Mouralidarane A, Samuelsson AM, Matthews P, Pombo J, Morgan M, McKee C, Soeda J, Novelli M, Poston L, Taylor P. Maternal obesity programmes offspring development of non-alcoholic fatty pancreas disease. Biochem Biophys Res Commun 2010;394:24–28.
54. Tamashiro KL, Terrillion CE, Hyun J, Koenig JI, Moran TH. Prenatal stress or high-fat diet increases susceptibility to diet-induced obesity in rat offspring. Diabetes 2009;58:1116–1125.
55. Sun B, Purcell RH, Terrillion CE, Yan J, Moran TH, Tamashiro KL. Maternal high-fat diet during gestation or suckling differentially affects offspring leptin sensitivity and obesity. Diabetes 2012;61:2833–2841.
56. Martins MR, Vieira AK, de Souza EP, Moura AS. Early overnutrition impairs insulin signaling in the heart of adult Swiss mice. J Endocrinol 2008;198:591–598.
57. Aubert R, Suquet JP, Lemonnier D. Long-term morphological and metabolic effects of early under- and over-nutrition in mice. J Nutr 1980;110:649–661.
58. Fiorotto ML, Burrin DG, Perez M, Reeds PJ. Intake and use of milk nutrients by rat pups suckled in small, medium, or large litters. Am J Physiol 1991;260:R1104–R1113.
59. Rodrigues AL, de Moura EG, Passos MC, Trevenzoli IH, da Conceição EP, Bonono IT, Neto JF, Lisboa PC. Postnatal early overfeeding induces hypothalamic higher SOCS3 expression and lower STAT3 activity in adult rats. J Nutr Biochem 2011;22:109–117.
60. You S, Götz F, Rohde W, Dörner G. Early postnatal overfeeding and diabetes susceptibility. Exp Clin Endocrinol 1990;96:301–306.
61. Waterland RA, Garza C. Early postnatal nutrition determines adult pancreatic glucose-responsive insulin secretion and islet gene expression in rats. J Nutr 2002;132:357–364.
62. Steegers-Theunissen RP, Obermann-Borst SA, Kremer D, Lindemans J, Siebel C, Steegers EA, Slagboom PE, Heijmans BT. Periconceptional maternal folic acid use of 400 microg per day is related to increased methylation of the IGF2 gene in the very young child. PLoS One 2009;4:e7845.
63. Cooney CA, Dave AA, Wolff GL. Maternal methyl supplements in mice affect epigenetic variation and DNA methylation of offspring. J Nutr 2002;132:2393S–2400S.
64. Waterland RA, Travisano M, Tahiliani KG. Diet-induced hypermethylation at agouti viable yellow is not inherited transgenerationally through the female. FASEB J 2007;21:3380–3385.
65. Waterland RA, Travisano M, Tahiliani KG, Rached MT, Mirza S. Methyl donor supplementation prevents transgenerational amplification of obesity. Int J Obes (Lond) 2008;32:1373–1379.
66. Dolinoy DC, Weidman JR, Waterland RA, Jirtle RL. Maternal genistein alters coat color and protects Avy mouse offspring from obesity by modifying the fetal epigenome. Environ Health Perspect 2006;114:567–572.
67. Dolinoy DC, Huang D, Jirtle RL. Maternal nutrient supplementation counteracts bisphenol A-induced DNA hypomethylation in early development. Proc Natl Acad Sci U S A 2007;104:13056–13061.